Skip to content

CAPIOX CX*RX05REARecalls & reported problems

Terumo Corporation · CAPIOX RX Oxygenator · Class 2

Adverse event reports
2
Deaths reported
1
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 04987350739025), received between Mar 6, 2025 and Mar 17, 2025 — classified as 1 death, 1 malfunction.

The most frequently reported specific device problem is “Failure to Deliver” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 2 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Failure to Deliver1
  • Material Deformation1

Patient problems

  • Insufficient Information1
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 17, 2025Material Deformation; Material Deformation

    THE USER FACILITY REPORTED THAT THE OXYGENATOR INVOLVED WAS DEFECTIVE. THERE EVENT DID NOT RESULT IN DELAY IN THE BEGINNING OR CONTINUING THE SURGICAL PROCEDURE. THE OUT-FLOW CONNECTION UNDER RED CAPPED WAS BENT. THE PERFUSIONIST NOTED THE DEFECT DURING SETUP EXAMINATION, AND THE OXYGENATOR WAS NOT USED. THE PRODUCT WAS CHANGED OUT, AND THE SURGERY WAS COMPLETED SUCCESSFULLY. THERE WAS NO PATIENT INJURY, AND NO BLOOD LOSS WAS REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21621533 ↗
  • DeathMar 6, 2025Failure to Deliver; Failure to Deliver

    THE USER FACILITY REPORTED THAT THE INVOLVED OXYGENATOR DID NOT FUNCTION PROPERLY. THE EVENT OCCURRED DURING CARDIOPULMONARY BYPASS. THE EVENT RESULTED IN DELAY IN BEGINNING OR CONTINUING THE SURGICAL PROCEDURE. AFTER 3 HOURS AND 40 MINUTES THE DEVICE'S ABILITY TO OXYGENATE WAS NOT FUNCTIONING. SWEEP WAS AT 1.2 LPM AND 60% FIO2, PO2 WAS 295 THEN NEXT ENTRY FELL TO 95 AND CONTINUED FALLING DESPITE INCREASES IN FIO2 AND SWEEP. A SECOND OXYGENATOR WAS ADDED TO THE RECIRCULATION LINE TO FACILITATE OXYGENATION. THEY DID NOT CHANGE OUT THE OXYGENATOR THEY ADDED ANOTHER OXYGENATOR TO THE CIRCUIT TO FINISH THE CASE. THE SURGERY WAS COMPLETED SUCCESSFULLY. NO BLOOD LOSS WAS REPORTED. A DEATH OCCURRED. THE PATIENT DID NOT DIE IN SURGERY, THEY DIED IN INTENSE CARE UNIT (ICU).

    Patient problems: Insufficient Information

    MAUDE report 21536636 ↗

Other OXYGENATOR, CARDIOPULMONARY BYPASS devices

All OXYGENATOR, CARDIOPULMONARY BYPASS devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.